The lack of detail has prompted questions and skepticism about how many of these shots will reach their intended recipients.
Related posts:
U.S. searches for new AstraZeneca vaccine producer after Emergent mix-up
Feds rethink vaccination strategy as slowing demand reveals stark divide
Fauci: ‘I don’t think we’re going to see lockdowns’
FDA targets early September for approving Pfizer’s Covid-19 vaccine
Fauci urges more testing to track breakthrough Covid cases
This rural area escaped the worst of Covid-19 — but it can’t outrun Delta
No ‘clear’ messaging about pandemic from Biden and Trump administrations, Maryland’s governor says
Ire over pharmacy middlemen fuels lobbying blitz
FDA authorizes Pfizer Covid booster for 16-, 17-year-olds
China’s Tianjin testing all residents after Omicron found
The doctor who sees you now may have Covid
Biden administration lays out rules for reimbursing at-home Covid tests
